Glenmede Trust’s Allergan Inc AGN Stock Holding History

Glenmede Trust’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-290,258	Closed	-$61.7M	–	2710
2014 Q4	$61.7M	Sell	290,258 -39,885	-12%	-$7.93M	0.48%	35
2014 Q3	$58.8M	Buy	330,143 +18,574	+6%	+$3.08M	0.52%	36
2014 Q2	$52.7M	Sell	311,569 -99,806	-24%	-$15.5M	0.47%	45
2014 Q1	$51M	Sell	411,375 -3,588	-0.9%	-$437K	0.47%	48
2013 Q4	$46.1M	Buy	414,963 +97,846	+31%	+$9.35M	0.47%	47
2013 Q3	$28.7M	Buy	317,117 +25,479	+9%	+$2.29M	0.34%	64
2013 Q2	$24.6M	Buy	+291,638	New	+$30.3M	0.31%	68

Other funds holding AGN

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return

ECM

Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return

HFS

HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Glenmede Trust's AGN Position: Q1 2015 in Review

Glenmede Trust sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 290,258 shares — an estimated $61.7M sold.

Glenmede Trust first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $61.7M in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

Glenmede Trust reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
Glenmede Trust sold 290,258 Allergan Inc shares in Q1 2015, an estimated $61.7M.
Glenmede Trust first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
Glenmede Trust's Allergan Inc position peaked at $61.7M in Q4 2014.
5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Glenmede Trust's 13F filing for Q1 2015, filed 29 Apr 2015.